Dadal, Erlina C.

HRN: 00-03-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2025
CEFTRIAXONE 1G (VIAL)
08/26/2025
09/02/2025
IV
2g
Q 24H
DM Foot, Right
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines